Life Spine Announces First Surgical Cases of DYNA-LINK® Titanium With Barb Fixation

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of DYNA-LINK Titanium with Barb Fixation.

Life Spine notes DYNA-LINK Titanium Stand-Alone Anterior Lumbar System is a zero-profile, stand-alone device that offers surgeons a safe and reliable alternative to 360˚ fusion procedures. In addition to providing immediate fixation, multiple footprints, heights, screw options, and now barbs are available to accommodate various patient anatomies and pathologies to promote fusion.

“DYNA-LINK Titanium Barb offering provides an integrated supplemental fixation system that allows for a less invasive direct anterior approach. Barbs are preloaded within the inserter for the titanium implant, permitting seamless deployment of fixation for the cage and eliminating the need for angulated instruments,” said Dr. Ali Mesiwala of the DISC Sports & Spine Center in Newport Beach, California. “This potentially reduces surgical time and incision size and provides an ideal option to treat my patients in both the outpatient and inpatient setting.”

DYNA-LINK Titanium Features and Benefits:

  • Stand-Alone Device *barbs require supplemental fixation
  • Streamlined Barb Delivery Instrumentation
  • Osseo-Loc® Surface Technology
  • 37˚ to 45˚ Screw Angulation

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”